CEBPD and lymphoma: In addition to solid tumors, C/EBPδ gene expression is reduced and the C/EBPδ promoter is silenced by hypermethylation in the U937 human lymphoma derived cell line and in ~35% of lymphoma cells isolated from AML patients [22].